Insider · CIK 0001831127
Gregory Scott Duncan
directorceoofficer
Files at CRMD (CorMedix Inc.), DWTX (Dogwood Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | DWTX Dogwood Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +330,000 | $0.00 | $0 | 330,000 | Mar 6, 2026 |
| Jan 26, 2026 | CRMD CorMedix Inc. | AGrant or award Common Stock | +30,453 | $0.00 | $0 | 68,786 | Jan 27, 2026 |
| Dec 4, 2025 | DWTX Dogwood Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +460,000 | $0.00 | $0 | 460,000 | Dec 5, 2025 |
| Sep 16, 2025 | CRMD CorMedix Inc. | MOption exercise Common Stock | +13,333 | $8.32 | $111k | 38,333 | Sep 18, 2025 |
| Sep 16, 2025 | CRMD CorMedix Inc. | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -13,333 | $0.00 | $0 | 6,667 | Sep 18, 2025 |
| Jun 27, 2025 | DWTX Dogwood Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jul 1, 2025 |
| Jan 17, 2025 | CRMD CorMedix Inc. | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 25,000 | Jan 22, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.